New diabetes guidelines imminent, Jardiance sales may surge

New diabetes guidelines imminent, Jardiance sales may surge

This post was originally published on this site

A screen displays trading information for stocks; Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange in New York City, U.S., May 16, 2016. Two leading U.S. medical societies are poised in the coming weeks to issue new diabetes treatment guidelines reflecting the lifesaving cardiovascular effects of Eli Lilly’s Jardiance in a move expected to drive up the drug’s sales.